Schizophrenia is a chronic, severe, and disabling brain disorder that has affected people throughout history. It is characterized by hallucinations, delusions, and disorganized thinking and behavior. Symptoms may include talking to oneself, hearing voices, paranoia, and poor emotional control. People with schizophrenia often experience difficulties with daily activities, including work, school, and relationships. The cause of schizophrenia is unknown, but it is thought to involve a combination of environmental and genetic factors. It is believed to be related to a disruption in how the brain processes dopamine, a neurotransmitter involved in understanding and interpreting reality. Schizophrenia is also linked to abnormalities in brain structure and function, which can be seen in brain imaging scans, such as MRI. Treatment for schizophrenia is focused on controlling symptoms and improving quality of life. Common medications used for treatment include antipsychotic drugs like clozapine, risperidone, and olanzapine. These help to reduce hallucinations, delusions, and other symptoms. Therapy can also be used to help people cope with the social, emotional, and cognitive challenges of their disorder. Additionally, it is important for individuals to take an active role in managing their symptoms and recovery. Schizophrenia can be a difficult disorder to manage and treatment can often involve a multidisciplinary approach. It is important to remember that people with schizophrenia can still lead meaningful and productive lives with the proper support and treatment.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States